Patent · US Expired

Certain 2,4-diamino-5-(2,3-dihalophenyl)-6-substituted pyrimidines which are pharmacologically active CNS compounds

US5597828A · kind A · utility

12Cited by
14References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 6, 1995
Grant dateJan 28, 1997
Priority date
Expiry dateJun 6, 2015

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D239/58
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A class of substituted phenylpyrimidine compounds are disclosed which are potent inhibitors of the excitatory amino acid, glutamate. Such compounds are useful in the treatment or prevention of a range of CNS disorders including cerebral ischaemic damage and epilepsy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.